1. ScholarBank@NUS

Wan-Teck Darren Lim

rp07954

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Wan-Teck Darren Lim
Variants
Lim, W.-T.
 
Main Affiliation
 
Faculty
 
Email
gmslwtd@nus.edu.sg
 

Publications

Refined By:
Subject:  Life Sciences & Biomedicine
Subject:  Oncology

Results 1-11 of 11 (Search time: 0.006 seconds).

Issue DateTitleAuthor(s)
127-Sep-2021Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signaturesTeng, Yvonne HF ; Quah, Hong Sheng ; Suteja, Lisda; Dias, Joao ML; Mupo, Annalisa; Bashford-Rogers, Rachael JM; Vassiliou, George S; Chua, Melvin LK; Tan, Daniel SW ; Lim, Darren WT ; Iyer, N Gopalakrishna 
226-Apr-2016Concordance of anaplastic lymphoma kinase (ALK) gene rearrangements between circulating tumor cells and tumor in non-small cell lung cancerTan, Chye Ling ; Lim, Tse Hui ; Lim, Tony KH; Tan, Daniel Shao-Weng ; Chua, Yong Wei; Ang, Mei Kim ; Pang, Brendan ; Lim, Chwee Teck ; Takano, Angela ; Lim, Alvin Soon-Tiong ; Leong, Man Chun; Lim, Wan-Teck 
330-Mar-2021Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutationsChang, Gee-Chen; Lam, David Chi-Leung; Tsai, Chun-Ming; Chen, Yuh-Min; Shih, Jin-Yuan; Aggarwal, Shyam; Wang, Shuhang; Kim, Sang-We; Kim, Young-Chul; Wahid, Ibrahim; Li, Rubi; Lim, Darren Wan-Teck ; Sriuranpong, Virote; Chan, Raymond Tsz-Tong; Lorence, Robert M; Carriere, Philippe; Raabe, Christina; Cseh, Agnieszka; Park, Keunchil
41-Apr-2019First-line afatinib for the treatment of EGFR mutation-positive non-small-cell lung cancer in the 'real-world' clinical settingPark, Keunchil; Lim, Darren Wan-Teck ; Okamoto, Isamu; Yang, James Chih-Hsin
53-Dec-2018Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastasesTan, Wan-Ling ; Ng, Quan Sing ; Lim, Cindy; Tan, Eng Huat ; Toh, Chee Keong; Ang, Mei-Kim ; Kanesvaran, Ravindran ; Jain, Amit ; Tan, Daniel SW ; Lim, Darren Wan-Teck 
624-Dec-2018Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases (vol 18, 1198, 2018)Tan, Wan-Ling ; Ng, Quan Sing ; Lim, Cindy; Tan, Eng Huat ; Toh, Chee Keong; Ang, Mei-Kim ; Kanesvaran, Ravindran ; Jain, Amit ; Tan, Daniel SW ; Lim, Darren Wan-Teck 
72-Oct-2019Liquid biopsy: one cell at a timeLim, Su Bin; Lee, Wen Di ; Vasudevan, Jyothsna; Lim, Wan-Teck ; Lim, Chwee Teck 
822-May-2019Pan-cancer analysis connects tumor matrisome to immune responseLim, Su Bin; Chua, Melvin Lee Kiang ; Yeong, Joe Poh Sheng; Jin, Swee Jin; Lim, Wan-Teck ; Lim, Chwee Teck 
930-Dec-2019Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohortsBang, Yung-Jue; Su, Wu-Chou; Schuler, Martin; Nam, Do-Hyun; Lim, Wan Teck ; Bauer, Todd M; Azaro, Analia; Poon, Ronnie Tung Ping; Hong, David; Lin, Chia-Chi; Akimov, Mikhail; Ghebremariam, Samson; Zhao, Sylvia; Giovannini, Monica; Ma, Brigette
101-Nov-2021Prognostic Matrisomal Gene Panel and Its Association with Immune Cell Infiltration in Head and Neck CarcinomasBelotti, Yuri ; Lim, Su Bin; Iyer, Narayanan Gopalakrishna ; Lim, Wan-Teck ; Lim, Chwee Teck 
111-Nov-2017Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer)Nokihara, H; Lu, S; Mok, TSK; Nakagawa, K; Yamamoto, N; Shi, YK; Zhang, L; Soo, RA ; Yang, JC; Sugawara, S; Nishio, M; Takahashi, T; Goto, K; Chang, J; Maemondo, M; Ichinose, Y; Cheng, Y; Lim, WT ; Morita, S; Tamura, T